Order Article Reprints

Hirasawa Y, Satomura A, Okada M, Utsugi M, Ogura H, Yanagi T, Nakamori Y, Takehara M, Murakami K, Nagao G, et al. Urinary microRNAs as Prognostic Biomarkers for Predicting the Efficacy of Immune Checkpoint Inhibitors in Patients with Urothelial Carcinoma. Cancers. 2025; 17(16):2640. https://doi.org/10.3390/cancers17162640

Hirasawa, Yosuke, Atsushi Satomura, Mitsuo Okada, Mieko Utsugi, Hiroki Ogura, Tsuyoshi Yanagi, Yuta Nakamori, Masayuki Takehara, Kokichi Murakami, Go Nagao, and et al. 2025. "Urinary microRNAs as Prognostic Biomarkers for Predicting the Efficacy of Immune Checkpoint Inhibitors in Patients with Urothelial Carcinoma" Cancers 17, no. 16: 2640. https://doi.org/10.3390/cancers17162640

Hirasawa, Y., Satomura, A., Okada, M., Utsugi, M., Ogura, H., Yanagi, T., Nakamori, Y., Takehara, M., Murakami, K., Nagao, G., Kashima, T., Satake, N., Ando, Y., Mikami, M., Mizunuma, M., Ichikawa, Y., & Ohno, Y. (2025). Urinary microRNAs as Prognostic Biomarkers for Predicting the Efficacy of Immune Checkpoint Inhibitors in Patients with Urothelial Carcinoma. Cancers, 17(16), 2640. https://doi.org/10.3390/cancers17162640